Portfolio company
Ancora Biotech
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
The company develops multi-specific antibody therapeutics to treat patients with cancer, inflammatory disorders, and chronic hepatitis B infections.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Ankyra Therapeutics
This biotechnology company develops anchored immunotherapy treatments for patients with cancer and other serious immune-mediated diseases.
Radiant Biotherapeutics
This company develops multi-specific antibody therapies to treat patients with cancer and infectious diseases.
Avidicure
This biotechnology company develops multifunctional antibody therapies for cancer patients to activate immune responses while reducing toxicity.
ATB Therapeutics
The company develops engineered antibody therapies for patients with cancer and autoimmune diseases using a proprietary bioengineering platform.
Bambusa Therapeutics
The company develops bispecific antibodies for patients with immunological and inflammatory disorders.
Laigo Bio
This company develops bispecific antibody therapies that remove disease-causing membrane proteins to treat patients with cancer and autoimmune disorders.
Teneobio
This clinical-stage biotechnology company develops human heavy-chain antibodies and multispecific biologics to treat patients with cancers, autoimmune disorders and infectious diseases.
VelaVigo
This biotechnology company develops multi-specific antibodies and antibody-drug conjugates for patients with cancer and autoimmune diseases.